- Home
- BNBX vs TIVC Comparison
BNBX vs TIVC Comparison
Compare BNBX & TIVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNBX | TIVC |
|---|---|---|
| Founded | 1983 | 2016 |
| Country | United States | United States |
| Employees | 26 | N/A |
| Industry | Other Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BNBX | TIVC |
|---|---|---|
| Price | $0.52 | $1.31 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 375.2K | 48.4K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $780,000.00 |
| Revenue This Year | $253.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.47 | $0.75 |
| 52 Week High | $6.17 | $6.95 |
Technical Indicators
Market Signals| Indicator | BNBX | TIVC |
|---|---|---|
| Relative Strength Index (RSI) | 30.56 | 65.92 |
| Support Level | N/A | $0.79 |
| Resistance Level | $0.82 | $1.36 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 12.23 | 92.00 |
Price Performance
Historical ComparisonAbout BNBX Applied DNA Sciences Inc.
BNB Plus Corp focuses on digital asset treasury management of BNB. The group is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company's differentiated blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space.
About TIVC Tivic Health Systems Inc.
Tivic Health Systems Inc is a late-stage biopharmaceutical company focused on the development of biologics, with its lead product candidate, Entolimod, a TLR5 agonist, being developed for acute radiation syndrome and oncology-related indications. The company operates through two segments: a biopharma segment focused on product development and commercialization, and a contract development and manufacturing organization (CDMO) segment providing manufacturing and development services through its subsidiary.